# Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

> **NCT01765660** · PHASE2 · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Graft-versus-host Disease

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells
- **BIOLOGICAL:** Non-mesenchymal stem cells

## Key facts

- **NCT ID:** NCT01765660
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-01-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01765660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01765660, "Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01765660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*